RNU1-141P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU1-141P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU1-141P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU1-141P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-141P expression acts as an unfavorable survival marker.

LIHC, LUSC, and KIRC are the cancer types where RNU1-141P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LIHCOSTertileAll0.0730.786<.001108view →
LUSCOSTertileAll0.0810.764<.00172view →
KIRCDFSTertileAll0.7160.875.00348view →
LAMLDFSTertileAll0.0270.583<.00136view →
THCADFSTertileII,III,IV0.1590.877<.00127view →
LUADOSTertileAll0.2380.697.01527view →
KIRPOSTertileAll0.1360.711<.00121view →
GBMDFSTertileAll0.0480.257.00118view →
PCPGDFSTertileAll0.0700.936<.00118view →
STADDFSTertileIV0.0830.379.0019view →
Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

Exploration